8129.T

Toho Holdings Co., Ltd. [8129.T] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

8129.T Stock Summary

Earnings have grown 9.67% per last year.

EPS has been increasing for the past 3 years (Yearly statements)

Earnings are expected to fall -100% next year

8129.T has less than 1 year of cash runway

Top 10 Correlated ETFs

8129.T

Top 10 Correlated Stocks

8129.T

In the News

8129.T Financial details

Company Rating

Buy

Market Cap

225.49B

Income

17.57B

Revenue

1450.3B

Book val./share

3800.55

Cash/share

2010.69

Dividend

Dividend %

1.03%

Employees

7.7K

Optionable

Shortable

Yes

Earnings

10 May 2024

P/E

11.82

Forward P/E

PEG

2.81

P/S

0.16

P/B

0.91

P/C

1.8

P/FCF

Quick Ratio

0.98

Current Ratio

1.23

Debt / Equity

0.15

LT Debt / Equity

0.12

EPS (TTM)

269.62

EPS next Y

EPS next Q

EPS this Y

3.69%

EPS next Y

EPS next 5Y

EPS last 5Y

2.04%

Revenue last 5Y

2.59%

Revenue Q/Q

0.27%

EPS Q/Q

-34.85%

SMA20

7.14%

SMA50

15.16%

SMA100

9.02%

Inst Own

Inst Trans

ROA

ROE

ROC

0.05%

Gross Margin

Oper. Margin

Profit Margin

Payout

Shs Outstand

Shs Float

Target Price

52W Range

2520.0-3753.0

52W High

-3.65%

52W Low

+43.49%

RSI

Rel Volume

1.06

Avg Volume

270.49K

Volume

286.8K

Perf Week

-2.03%

Perf Month

12.54%

Perf Quarter

11.3%

Perf Half Y

12.96%

Beta

-0.109

Volatility

22.9%, 124.23%

Prev Close

-0.96%

Price

3616

Change

-1.74%

8129.T Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-03-31

Metric	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	15.67K	18.17K	17.17K	17.95K	20.04K
Net income per share	177.78	233.34	70.76	189.69	196.69
Operating cash flow per share	172.2	155.49	124.35	231.69	-0.13
Free cash flow per share	123.49	-43.92	43.17	172.11	-36.48
Cash per share	943.02	1.21K	1.23K	1.25K	1.11K
Book value per share	2.74K	3.32K	3.37K	3.42K	3.5K
Tangible book value per share	2.69K	3.26K	3.29K	3.35K	3.43K
Share holders equity per share	2.74K	3.32K	3.37K	3.42K	3.5K
Interest debt per share	485.84	643.71	623.74	578.67	547.78
Market cap	218.34B	157.68B	143.14B	130.48B	162.85B
Enterprise value	176.58B	118.2B	93.95B	76.96B	114.54B
P/E ratio	15.75	9.72	28.69	9.75	11.95
Price to sales ratio	0.18	0.12	0.12	0.1	0.12
POCF ratio	16.26	14.58	16.32	7.98	-18.09K
PFCF ratio	22.67	-51.61	47.02	10.75	-64.42
P/B Ratio	1.02	0.68	0.6	0.54	0.67
PTB ratio	1.02	0.68	0.6	0.54	0.67
EV to sales	0.14	0.09	0.08	0.06	0.08
Enterprise value over EBITDA	6.33	3.99	5.4	3.04	4.46
EV to operating cash flow	13.15	10.93	10.72	4.71	-12.73K
EV to free cash flow	18.34	-38.69	30.86	6.34	-45.31
Earnings yield	0.06	0.1	0.03	0.1	0.08
Free cash flow yield	0.04	-0.02	0.02	0.09	-0.02
Debt to equity	0.18	0.19	0.18	0.17	0.16
Debt to assets	0.06	0.07	0.06	0.06	0.05
Net debt to EBITDA	-1.5	-1.33	-2.83	-2.12	-1.88
Current ratio	1.2	1.26	1.29	1.27	1.21
Interest coverage	526.1	586.33	54.47	164.83	177.96
Income quality	0.64	0.45	0.85	0.81	0
Dividend Yield	0.01	0.02	0.02	0.02	0.01
Payout ratio	0.15	0.15	0.49	0.16	0.16
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.01	0.01	0.01	0.01	0.01
Capex to operating cash flow	-0.28	-1.28	-0.65	-0.26	279.89
Capex to revenue	0	-0.01	0	0	0
Capex to depreciation	-0.59	-2.38	-0.84	-0.6	-0.39
Stock based compensation to revenue	0	0	0	0	0
Graham number	3.31K	4.18K	2.32K	3.82K	3.94K
ROIC	0.04	0.04	0.01	0.03	0.03
Return on tangible assets	0.02	0.02	0.01	0.02	0.02
Graham Net	-1.43K	-1.35K	-1.38K	-1.37K	-1.48K
Working capital	79.16B	99.96B	110.19B	110.29B	93.33B
Tangible asset value	209.87B	226.4B	232.29B	236.1B	237.54B
Net current asset value	29.55B	38.14B	41.13B	52.01B	61.15B
Invested capital	0.18	0.19	0.18	0.17	0.16
Average receivables	300.09B	299.98B	298.57B	306.35B	321.98B
Average payables	371.75B	364.73B	356.05B	363.49B	377.58B
Average inventory	75.84B	77.13B	76.03B	78.38B	85.89B
Days sales outstanding	89.95	86.29	89.98	90.61	86.65
Days payables outstanding	123.07	112.88	117.28	116.68	110.02
Days of inventory on hand	25.84	24.05	25.1	25.34	26.12
Receivables turnover	4.06	4.23	4.06	4.03	4.21
Payables turnover	2.97	3.23	3.11	3.13	3.32
Inventory turnover	14.13	15.17	14.54	14.4	13.98
ROE	0.06	0.07	0.02	0.06	0.06
Capex per share	-48.72	-199.41	-81.18	-59.58	-36.35

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q3

Metric	2022-12-31	2023-03-31	2023-06-30	2023-09-30	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	5.47K	4.94K	5.3K	5.94K	6K
Net income per share	85.9	61.16	23.06	112.26	73.14
Operating cash flow per share	45.35	53.1	48.72	50.05	50.95
Free cash flow per share	45.35	53.1	48.72	50.05	50.95
Cash per share	1.63K	1.25K	1.19K	2.2K	2.01K
Book value per share	3.48K	3.63K	3.64K	3.79K	3.8K
Tangible book value per share	3.4K	3.55K	3.56K	3.71K	3.72K
Share holders equity per share	3.48K	3.63K	3.64K	3.79K	3.8K
Interest debt per share	535.3	566.03	568.9	573.36	567.21
Market cap	151.89B	157.38B	175.48B	207.14B	206.52B
Enterprise value	75.95B	109.06B	120.43B	106.31B	113.98B
P/E ratio	6.4	9.61	28.69	7.14	11.01
Price to sales ratio	0.4	0.48	0.5	0.54	0.54
POCF ratio	48.47	44.26	54.33	64.05	63.23
PFCF ratio	48.47	44.26	54.33	64.05	63.23
P/B Ratio	0.63	0.65	0.73	0.85	0.85
PTB ratio	0.63	0.65	0.73	0.85	0.85
EV to sales	0.2	0.33	0.34	0.28	0.3
Enterprise value over EBITDA	10.09	14.63	29.6	15.24	16.96
EV to operating cash flow	24.23	30.67	37.28	32.87	34.9
EV to free cash flow	24.23	30.67	37.28	32.87	34.9
Earnings yield	0.04	0.03	0.01	0.04	0.02
Free cash flow yield	0.02	0.02	0.02	0.02	0.02
Debt to equity	0.15	0.16	0.16	0.15	0.15
Debt to assets	0.05	0.05	0.05	0.05	0.05
Net debt to EBITDA	-10.09	-6.48	-13.53	-14.45	-13.77
Current ratio	1.19	1.21	1.25	1.23	1.23
Interest coverage	297.87	236.72	123.53	289.94	339.2
Income quality	0.53	0.87	2.11	0.45	0.7
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.01	0.01	0.01	0.01	0.01
Capex to operating cash flow	0	0	0	0	0
Capex to revenue	0	0	0	0	0
Capex to depreciation	0	0	0	0	0
Stock based compensation to revenue	0	0	0	0	0
Graham number	2.59K	2.23K	1.37K	3.1K	2.5K
ROIC	0.01	0.01	0	0.01	0.01
Return on tangible assets	0.01	0.01	0	0.01	0.01
Graham Net	-1.81K	-1.43K	-1.88K	-1.6K	-1.81K
Working capital	95.56B	93.33B	110.32B	117.64B	119.42B
Tangible asset value	235.07B	237.54B	235.86B	239.56B	238.17B
Net current asset value	55.19B	61.15B	54.79B	64.16B	66.72B
Invested capital	0.15	0.16	0.16	0.15	0.15
Average receivables	341.96B	343.81B	328.86B	341.57B	356.78B
Average payables	437.92B	426.98B	394.31B	434.58B	469.79B
Average inventory	88.96B	93.47B	89.53B	88.03B	91.51B
Days sales outstanding	85.21	89.69	84.08	83.29	83.87
Days payables outstanding	120.94	114.76	111.98	118.42	119.68
Days of inventory on hand	24.64	27.24	24.32	22.49	23.89
Receivables turnover	1.06	1	1.07	1.08	1.07
Payables turnover	0.74	0.78	0.8	0.76	0.75
Inventory turnover	3.65	3.3	3.7	4	3.77
ROE	0.02	0.02	0.01	0.03	0.02
Capex per share	0	0	0	0	0

8129.T Dividend History

8129.T Frequently Asked Questions

What is Toho Holdings Co., Ltd. stock symbol ?

Toho Holdings Co., Ltd. is a JP stock and trading under the symbol 8129.T

What is Toho Holdings Co., Ltd. stock quote today ?

Toho Holdings Co., Ltd. stock price is $3616 today.

Is Toho Holdings Co., Ltd. stock public?

Yes, Toho Holdings Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 270.49K
Market Capitalization 225.49B
Employee 7.7K
CEO Mr. Atsushi Udoh
Headquarters Tokyo,JP
IPO Date 2002-12-11
Website https://www.tohohd.co.jp

Toho Holdings Co., Ltd. engages in the wholesale distribution of pharmaceutical products in Japan. It sells prescription pharmaceuticals, reagents, medical devices and materials, OTC drugs, health foods, preventive care, clinical care, community healthcare linkage, and home medical and nursing care, as well as provides support services, including the development and sale of customer support systems, assistance in the start-up of medical institutions and pharmacies, management consulting services, medical support, and personnel recruitment. The company also engages in dispensing pharmacy business; manufacture and sale of generic drugs; and site management organization business that assists various medical institutions with clinical trials under contract, as well as sells software to medical institutions. In addition, it provides various customer support systems, including ENIF, an information terminal for pharmaceutical ordering; ENI-Pharmacy, a support system for the separation of dispensing and prescribing functions; LXMATE HeLios a medical care appointment system; KAITOS, an online medical consultation and medication guidance system; ENIFwin, an inventory control system for large hospitals; ENIFvoice SP/ ENIFvoice SP + A/ ENIFvoice Core, a supporting system for electronic medication history recording with voice recognition; and ENIF Nurse, an operation support terminal for home-visit nurses; and logistics systems. The company was incorporated in 1948 and is headquartered in Tokyo, Japan.